Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Scandinavian Journal of Gastroenterology|August 23, 2002
Interferon alfa-2b alone or combined with recombinant granulocyte-macrophage colony-stimulating factor as treatment of chronic hepatitis CK Grønbaek, H Bygum Krarup, H Ring-Larsen, et al.
Leukemia|October 6, 2000
Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphomaK Grønbaek, P de Nully Brown, M B Møller, et al.
The British Journal of Dermatology|May 16, 2000
Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 casesK Grønbaek, P H Møller, T Nedergaard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypesP thor Straten, P Guldberg, K Grønbaek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study GroupF d'Amore, H Brincker, K Grønbaek, et al.
The British Journal of Dermatology|February 14, 2002
A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletionH Knudsen, K Grønbaek, P thor Straten, et al.
Blood|October 27, 1998
Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunityK Grønbaek, P T Straten, E Ralfkiaer, et al.
Leukemia|August 11, 1998
Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRbK Grønbaek, T Nedergaard, M K Andersen, et al.
Journal of Clinical Monitoring and Computing|August 20, 2024
Prognostic value of heart rate variability for risk of serious adverse events in continuously monitored hospital patientsNikolaj Aagaard, Markus Harboe Olsen, Oliver Wiik Rasmussen, et al.
Leukemia|January 1, 1997
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AMLP de Nully Brown, T Hoffmann, O P Hansen, et al.
Pageof 3